List of redirects

Showing below up to 50 results in range #40,411 to #40,460.

40411. PRIMI → Pro-Urokinase For Myocardial Infarction
40412. PRIMO-CABG → Pexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft Surgery Study
40413. PRIMO-CABG II → Pexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft II
40414. PRINCE → Effect Of Statin Therapy On C-Reactive Protein Levels: The Pravastatin Inflammation/Crp Evaluation (Prince): A Randomized Trial And Cohort Study
40415. PRINCESS → Prevention Of Ischaemic Events By Early Treatment Of Cerivastatin After Acute Myocardial Infarction
40416. PRINCIPLE-TIMI 44 → The Prasugrel In Comparison To Clopidogrel For Inhibition Of Platelet Activation And Aggregation–Thrombolysis In Myocardial Infarction 44 Trial
40417. PRISM → Platelet-Receptor Inhibition For Ischemic Syndrome Management
40418. PRISM-PLUS → Platelet-Receptor Inhibition For Ischemic Syndrome Management In Patients Limited By Unstable Signs And Symptoms
40419. PRISM-Troponin → Troponin Levels Identify Cad Patients Likely To Benefit From Tirofiban: Results From The Prism-Troponin Study, A Substudy Of The Platelet Receptor Inhibition In Ischemic Syndrome Management Study
40420. PRISON II → Prospective Randomized Trial Of Sirolimus-Eluting And Bare Metal Stents In Patients With Chronic Total Occlusions
40421. PRKACB gene → PRKACB
40422. PRKAR1A gene → PRKAR1A
40423. PRL cell adenoma → Prolactinoma
40424. PRL cell tumor → Prolactinoma
40425. PRL secreting adenoma → Prolactinoma
40426. PRL secreting pituitary adenoma → Prolactinoma
40427. PRL tumor → Prolactinoma
40428. PRNT → Plaque reduction neutralization test
40429. PROCAM → Simple Scoring Scheme For Calculating The Risk Of Acute Coronary Events Based On The 10-Year Follow-Up Of The Prospective Cardiovascular Münster (Procam) Study
40430. PRODH → Proline oxidase
40431. PROFILE → Prospective Randomized Flosequinan Longevity Evaluation
40432. PROGRESS → Perindopril Protection Against Recurrent Stroke Study
40433. PROGRESS-1 → Coronary Stenting With Absorbable Metal Stents
40434. PROLONG study → PROLONG Study
40435. PROM → Premature rupture of membranes
40436. PROMM → Myotonic dystrophy
40437. PROSPER → PROSPER Trial
40438. PROTECT-CAD → Prospective Randomized Trial Of Direct Endomyocardial Implantation Of Bone Marrow Cells For Therapeutic Angiogenesis In Coronary Artery Diseases
40439. PROTECT - TIMI 30 → Randomized Trial To Evaluate The Relative Protection Against Post-Pci Microvascular Dysfunction And Post-Pca Ischemia Among Anti-Platelet And Anti-Thrombotic Agents
40440. PROTECT AF → Randomized Prospective Trial Of Percutaneous Left Atrial Appendage Closure Versus Warfarin For Stroke Prevention In Atrial Fibrillation
40441. PROTO oxidase → Protoporphyrinogen oxidase
40442. PROVED → Randomized Study Assessing The Effect Of Digoxin Withdrawal In Patients With Mild To Moderate Chronic Congestive Heart Failure: Results Of The Proved
40443. PROVE IT-TIMI 22 (Gatifloxacin) → PROVE IT-TIMI 22 Trial
40444. PROVE IT/TIMI 22 → PROVE IT-TIMI 22 Trial
40445. PROVE IT Trial → PROVE IT-TIMI 22 Trial
40446. PROVIDENCE 1 → Prospective Evaluation Of Rifalazil Effect On Vascular Symptoms Of Intermittent Claudication And Other Endpoints In Chlamydia Seropositive Patients
40447. PROXIMAL → Proximal Protection During Saphenous Vein Graft Intervention
40448. PROactive → Prospective Pioglitazone Clinical Trial In Macrovascular Events
40449. PRP → Platelet rich plasma
40450. PRPP → Phosphoribosyl pyrophosphate
40451. PRPS1 → Ribose-phosphate diphosphokinase
40452. PRSS1 → Trypsin 1
40453. PRWP → Poor R Wave Progression
40454. PR Interval → PR interval
40455. PR bleeding → Gastrointestinal bleeding
40456. PR depression → Depressed PR segment
40457. PR interval depression → Depressed PR segment
40458. PR interval lengthened → Long PR interval
40459. PR intervals → PR interval
40460. PR prolongation → Long PR interval